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Background: Probiotics are live microorganisms that confer nutrition- and health-promoting benefits if consumed
in adequate amounts. Concomitant with the demand for natural approaches to maintaining health is an increase in
inclusion of probiotics in food and health products. Since probiotic bacteria act as reservoir for antibiotic resistant
determinants, the transfer of these genes to pathogens sharing the same intestinal habitat is thus conceivable
considering the fact that dietary supplements contain high amounts of often heterogeneous populations of probiotics.
Such events can confer pathogens protection against commonly-used drugs. Despite numerous reports of antibiotic
resistant probiotics in food and biological sources, the antibiogram of probiotics from dietary supplements
remained elusive.
Findings: Here, we screened five commercially available dietary supplements for resistance towards antibiotics
of different classes. Probiotics of all batches of products were resistant towards vancomycin while batch-dependent
resistance towards streptomycin, aztreonam, gentamycin and/or ciprofloxacin antibiotics was detected for
probiotics of brands Bi and Bn, Bg, and L. Isolates of brand Cn was also resistant towards gentamycin, streptomycin
and ciprofloxacin antibiotics. Additionally, we also report a discrepancy between the enumerated viable bacteria
amounts and the claims of the manufacturers.
Conclusions: This short report has highlighted the present of antibiotic resistance in probiotic bacteria from
dietary supplements and therefore serves as a platform for further screenings and for in-depth characterization of the
resistant determinants and the molecular machinery that confers the resistance.Findings
Introduction
Probiotics are live microorganisms usually bacteria or
yeasts, that confer health-promoting benefits to the
host if consumed in adequate amounts. These benefits
range from improvement of intestinal health [1] and
immune response [2], to prevention of acute and
antibiotic-associated diarrhea [1], and cancer [3]. The
health-promoting attributes, mechanisms and strain-
specific benefits have been extensively reviewed elsewhere
[4]. Probiotic foods have gained widespread acceptance
and popularity [5, 6] as reflected by an estimated
growth of more than 10 % in economic value from
2009 to 2014 [7]. Due to increasing consumer demand
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number of food products especially in dairy foods such
as the probiotic-containing yoghurt, cheese, milk and
ice-cream [8].
Widespread use of probiotic bacteria in conjunction
and in close association with antibiotic use or rather
misuse, can over time establish a reservoir of antibiotic
resistant genes in probiotic bacteria [9]. While intrinsic
antibiotic resistance can be a desirable trait as probio-
tics help restore host gut microflora during a course of
antibiotics, however the transfer of resistant genes to
pathogenic bacteria offers serious clinical threats [10].
There is already a wide collection of literature reporting
resistance of lactic acid bacteria towards antibiotics of
the beta-lactams, macrolide, aminoglycoside, chloram-
phenicol and tetracycline classes [6, 11] and in some,
their corresponding resistant genes and mechanisms
have been characterized [9, 12]. Importantly, resistant
gene transfer that occurs at high frequency and persistis distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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and/or in vivo among Lactobacilli and from Lactobacilli
to pathogens [13] and vice versa [14]. These reports
have established probiotic bacteria as reservoir of anti-
biotic resistant genes that can be transferred to patho-
genic strains.
While the detection of antibiotic resistance in pro-
biotic strains from food and biological sources have in-
tensified, such reports from dietary supplements have
remained somewhat elusive. This is surprising consider-
ing the fact that probiotic dietary supplements contain
high amount and often a heterogeneous population of
probiotic bacteria both of which, are conditions that en-
courage the trafficking of resistant genes. Therefore, we
hypothesize that antibiotic resistant probiotics may be
present in dietary supplements.
Methods
Probiotic dietary supplements designated here as Bi,
Bn, Bg, Cn and L, were purchased from local pharmacy
or retail outlets (Table 1) and the ampicillin, aztreonam,
erythromycin, gentamycin, streptomycin, clindamycin,
vancomycin, ciprofloxacin, cephalexin and tetracycline
antibiotic discs were purchased from HiMedia, IndiaTable 1 The information of probiotic bacteria in dietary
supplements
Product Country manufactured Probiotic content Probiotic amount
(×106 CFU/capsule)












Bg Malaysia L. acidophilus, 2,000*
L. rhamnosus,
B. longum









*One capsule contains equal amounts of each probiotic strain. In products
where such information is not stated, equal contributions from each probiotic
content is assumed(Table 2). In order to recover and enumerate probiotic
bacteria [15], one capsule of dietary supplement was
dissolved in sterile double distilled water [16] and immedi-
ately platted on the de Man, Rogosa and Sharpe (MRS)
media (Difco, USA) which is selective for Lactobacilli. We
note that Lactobacilli constitute the majority of the pro-
biotic bacteria population in the dietary supplements
(Table 1) and have therefore excluded contributions of
other probiotic strains from the bacteria count and
from the subsequent antibiotic resistance screening
(Additional file 1). One capsule contains equal amounts of
each probiotic strain. In products where such informa-
tion is not stated, equal contributions from each pro-
biotic content is assumed. The dissolved samples
(106 CFU) were cultured overnight in MRS broth for
enrichment of probiotic bacteria after which the over-
night culture was adjusted to uniform concentrations of
7×106 CFU/mL of bacteria by spectroscopy (OD690nm)
prior to antibiotic susceptibility tests using commercial
antibiotic discs and according to the manufacturer’s in-
structions (Additional file 1).
Results and discussion
Viable bacteria were recovered on MRS media and their
amounts were enumerated prior to antibiotic suscepti-
bility tests. Probiotic bacteria, particularly the Lactoba-
cilli strains, from all brands of dietary supplements
were successfully recovered on MRS agar (Fig. 1a). The
recovered bacteria have different colony morphologies
of which two are particularly distinctive. One, a larger
sized opaque colony is present in all brands at similar
amounts to the other colony type that is smaller in size
and translucent, but appears to be far fewer in brands
Bn and L respectively (Fig. 1a). This suggests that there
is more than one type of probiotic strain in the respect-
ive products and this is consistent with the claims of
the manufacturers (Table 1). The bacteria enumeration
revealed that with the exception of brand Bn, samples
from all brands have bacteria amounts that are fewer
than that claimed by their manufacturers (Fig. 1b).
Most significant of these are samples from brands Bi,
Bg and L which have viable bacteria of only 6 %, 22 %
and 3 % of the amounts stated on their respective data-
sheets. The bacteria concentration of brand Cn is 57 %
of that claimed by the manufacturer while brand Bn
has a surprising bacteria count that is more than
double the stated amount. The enumerated bacteria
amounts were however above the recommended mini-
mum threshold of 106 CFU/capsule [17]. The over-
estimation of probiotic amounts in four of the five
products tested suggest that 1) a significant amounts of
bacteria have been compromised during the processing
stages which may include improper handling and stor-
age conditions or 2) the manufacturers have
Table 2 Classification and mode of action of antibiotics
Antibiotic Class Spectrum
Ampicillin (10 mcg) Semi-synthetic beta lactams Gram positive and Gram negative
Aztreonam (30 mcg) Mono-bactams Gram positive and Gram negative
Erythromycin (15 mcg) Macrolides Gram positive and Gram negative
Gentamicin (5 mcg) Aminoglycosides Gram positive and Gram negative, especially Pseudomonas
Streptomycin (10 mcg) Aminoglycosides Gram positive and Gram negative
Clindamycin (2 mcg) Lincomycins Gram positive and Gram negative, especially anaerobic Bacteroides
Vancomycin (30 mcg) Glycopeptides Gram positive and Gram negative, especially S. aureus
Cephalexin (30 mcg) Cephalosporin Gram positive
Tetracycline (30 mcg) Tetracycline Gram positive and Gram negative
Ciprofloxacin (10 mcg) Fluoroquinolones Gram positive and Gram negative, especially Bacillus anthracis
Fig. 1 The recovery and enumeration of probiotic bacteria from dietary supplements. (a) Representative MRS agar plates of probiotics
bacteria recovered from Bi, Bg, L, Bn and Cn dietary supplements showing different colony morphologies and densities. (b) Comparison
of the enumerated probiotics bacteria to that claimed by the manufacturers of the respective products (Table 1). Error bars represent
standard error of the mean (n = 2)
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products in an attempt to compete for consumers [18].
This finding seems to agree with other reports concern-
ing mislabeling, overestimation and misidentification of
probiotics in various food and health products [19]. It
is therefore doubtful that the health claims of the re-
spective products can be achieved by the inferior
amounts of viable probiotic bacteria although some re-
ports have claimed that viability is not essential and
that probiotic DNA or cell wall materials may be suffi-
cient to confer certain health effects [20]. This enumer-
ation provides useful preliminary data shedding light
on the accuracy and reliability of the probiotic bacteria
information detailed on the datasheet of dietary supple-
ments as regulations and legislations concerning prod-
uct labeling are currently lacking [21].
In the antibiotic resistant screening, clear inhibition
zones of > 0.5 cm were measured from the bacteria lawn
of isolates from all batches of brands Bi, Bn, Bg, Cn and
L towards ampicillin, erythromycin, clindamycin, cepha-
lexin and tetracycline antibiotics (Fig. 2b), suggesting noFig. 2 The antibiotic susceptibility profile of probiotic bacteria in the dietar
Bi, Bn, Bg, Cn and L dietary supplements layered with antibiotic discs show
presence of ‘clear’ inhibition zones. (b) Mean inhibition zones measured f
layered with the respective antibiotic discs. Error bars represent standard
in only certain batches of bacteria in the respective dietary supplementresistance towards these antibiotics. Meanwhile, inhib-
ition zones detected in only certain batches of the pro-
biotic products were that of brands Bi and Bn, Bg and
L in the presence of the respective streptomycin, aztre-
onam and gentamycin, streptomycin and ciprofloxacin
antibiotics (Fig. 2b). This batch-to-batch variation im-
plies that these resistances were not conferred by in-
trinsic genes but more likely a result of acquired mobile
genetic elements by a transfer event and this is a con-
cern because mobile elements such as plasmids and
transposons can be transferred from one cell to another
by conjugation [10]. Indeed, this mechanism has been
demonstrated in vitro where antibiotic resistant gene
transferred from one Lactobacillus to another and more
worryingly, also from Lactobacilli to other species in-
cluding pathogenic strains such as Staphylococcus [13]
and vice versa [22]. Streptomycin and gentamycin be-
long to the aminoglycosides and resistance towards this
group of antibiotic may be conferred by intrinsic Lacto-
bacilli aminoglycoside resistant genes aac(6’)-aph(2”),
ant(6), and aph(3’)-IIIa respectively [11]. Consistenty supplements. (a) Representative MRS agar plates of bacteria lawn of
ing susceptibility towards multiple antibiotics as characterized by the
rom the bacteria lawn of Bi, Bn, Bg, Cn and L dietary supplements
error of the mean (n ≥ 2) and (*) represents inhibition zone present
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no inhibition zone against the gentamycin and strepto-
mycin antibiotics besides also being resistant towards
ciprofloxacin (Fig. 2b). While resistance towards aztre-
onam, a derivative of the beta-Iactam antibiotics, may
be conferred by the blaZ genes which have also been
previously found in Lactobacilli [2], detection of cip-
rofloxacin resistance could not be attributed to known
fluoroquinolone resistance genes as they have not
been identified in Lactobacilli. Although probiotic
bacteria (predominantly Lactobacilli) of all products
were able to grow in the presence of vancomycin
(Fig. 2b), this is attributed to intrinsic vancomycin re-
sistant genes in Lactobacilli strains rather than a
transfer event. This intrinsic resistant gene prevents
vancomycin binding at the cytoplasmic end of their
cell walls due to replacement of the terminal amino
acid residue [23]. Notably, tetracycline and erythro-
mycin resistance were not detected in isolates of all
brands although genes conferring resistance towards
these classes of antibiotics (i.e. the tetracycline and
macrolides) are well-characterized in Lactobacilli [24].
Although reports on antibiotic resistance in probiotic
isolates of dietary supplements are elusive, such data
from foods [12] and biological sources [25] are widely
reported [6, 9, 16]. Further, resistant determinants
have also been identified with the resistance genes of
tetracycline (>10), aminoglycoside (at least 4) and
beta-lactam [12] constituting an expanding list of gen-
etic elements in Lactobacilli.
In summary, this is a pilot study that reports the
present of antibiotic resistance in probiotic bacteria in
dietary supplements thus expanding the screening of
antibiotic resistance to include this largely unexplored
but increasingly popular group of functional foods.
This study also serves as a platform for further
screenings and in-depth characterization of the resist-
ant determinants and the molecular machinery that con-
fers the resistance. In particular, resistant probiotics can
be isolated and identified by a combination of biochemical
tests and 16S rRNA gene sequencing analysis and the
antibiotic resistant genes characterized using degenerate
primers and/or a motif-based identification approach [26].
Manufacturing companies of dietary supplements should
incorporate antibiotic susceptibility screening using diag-
nostic tools such as microarray chips and PCR approaches
in the production chain. Additionally, curative strategies
such as the removal of genetic elements that harbor anti-
biotic resistance could also be applied to the relevant pro-
biotic strains. The latter has been applied to the probiotic
L. reuteri DSM 17938 whereby two resistant plasmids
were successfully removed from the parent L. reuteri
(ATCC 55730) [27] while not affecting the probiotic pro-
perties of the strain.Additional file
Additional file 1: Extended Materials and Methods.
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